Skip to content

Kodak Extachem Clinical Chemistry Slide Digoxin (Dgxn)

by Eastman Kodak Company

510(k) K942610

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

2 ongoing

This device is named in the recall

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 11 Oct 2026. What this means

Regulatory status

as of registry sync 11 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK942610 Date20 Oct 1994ClearedStatusActive

Recalls

4 recalls · 2 ongoing · FDA

  • 2 recalls, same reason

    • Ongoing Z-0902-2025 FDA Class II initiated 5 Dec 2024
    • Ongoing Z-0901-2025 FDA Class II initiated 5 Dec 2024

    Hemoglobin interference may occur at concentrations lower than the claimed 300 mg/dL, and may cause negatively biased digoxin results.

    • Terminated Z-0310-2014 FDA Class II initiated 12 Jun 2013

    Ortho Clinical Diagnostics is recalling Slide Dispense cartridges used with some VITROS Chemistry Product Slides due to slide dispense issues.

    • Terminated Z-2211-2012 FDA Class II initiated 28 Jun 2012

    Ortho Clinical Diagnostics revised the VITROS Chemistry Products DGXN Slides Instructions for Use (IFU) and removed heparin plasma as a recommended specimen type for VITROS DGXN Slides

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
LFM
Device Class
Class II
Regulation
21 CFR Part 862.3300
Advisory Committee
Clinical Toxicology
FDA Decision
SESE Substantially Equivalent

Other devices from Eastman Kodak Company

See all devices from Eastman Kodak Company →